Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Everolimus. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A known ✓ | P62942 | 9/20 | 0.87 |
| ▸ | MTOR | P42345 | 7/20 | 1.00 |
| ▸ | ABCC3 | O15438 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | ABCC2 | Q92887 | 2/20 | 1.00 |
| ▸ | RPTOR | Q8N122 | 2/20 | 1.00 |
| ▸ | MLST8 | Q9BVC4 | 2/20 | 1.00 |
| ▸ | KCNE1 | P15382 | 1/20 | 1.00 |
| ▸ | KCNQ1 | P51787 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.87 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Everolimus SCHEMBL22813561 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL23251030 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL23063577 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL20759396 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL25481687 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL23552755 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL23251039 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL24472605 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL23747774 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 | |
| Everolimus SCHEMBL21091316 | 1.00 | MTOR (1.00) | MTORABCC3ABCC4ABCB11ABCC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210009687-A1 | ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF | IMMUTEP S.A.S. (FR) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210009687-A1 | ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF | CD47, CD2, CD58 | FKBP1A 4287/4885MTOR 4344/4885ABCC3 3273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.